Moving On: Interactive Guide for Breast Cancer Survivors

描述：由于早期发现局限性癌症和治疗有效性的提高，乳腺癌幸存者的数量正在增加。HealthMark Multimedia，LLC提出了一个第一阶段SBIR项目，该项目将为乳腺癌幸存者制作一个原型CD-ROM，解决治疗后存在或持续存在的问题。 “继续前进"将为妇女提供信息和互动工具，在这一阶段为她们提供帮助。 在第一阶段，将开发一个原型用户界面，其中包括两个方面的内容（体力活动和重返工作岗位）和相关的互动工具。 产品开发将利用社会学习理论基础，将妇女的身体、心理社会/精神和日常需要转化为互动学习和支助产品。 该产品的可用性及其在增加用户知识和自我效能方面的有效性将在治疗后6个月至3年期间对40名女性进行测试。 在第二阶段，将制作教育和自我管理系统的其余部分。在第二阶段，我们将确定CD-ROM在增加生存行动知识和生存行动自我效能方面的有效性。 拟定商业应用： 本品具有直接销售给健康消费者的商业潜力， 制药公司作为增值的病人教育，为管理式医疗机构 和他们的成员，并作为一个由赞助商支持的互联网网站。 目前没有 为乳腺癌患者提供有关出现或持续问题的指导的互动程序 在他们完成治疗后。

DESCRIPTION: The number of breast cancer survivors is growing due to early detection of confined cancer and increased effectiveness of treatments. HealthMark Multimedia, LLC proposes a Phase I SBIR project that will result in a prototype CD-ROM for breast cancer survivors addressing issues that present or persist post-treatment. Moving On will provide women with information and interactive tools to assist them during this stage. In Phase I a prototype user interface will be developed with content in two areas (physical activity and return to work) and related interactive tools. Product development will use a social learning theory base to translate the physical, psycho-social/spiritual, and every day needs of women into an interactive learning and support product. The usability of the product and its effectiveness in increasing user knowledge and self-efficacy will be tested with 40 women between 6 months and 3 years post treatment. In Phase II, the remainder of the education and self-management system will be produced. During Phase II we will determine the effectiveness of the CD-ROM in increasing the knowledge of survivorship actions and self-efficacy of survivorship actions. PROPOSED COMMERCIAL APPLICATION: This product has commercial potential for direct sale to health consumers, for use by pharmaceutical companies as value-added patient education, for managed care organizations and their members, and as an Internet site supported by sponsors. Currently, there are no interactive programs offering breast cancer patients guidance on issues that arise or persist after they complete treatment.